{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:56:40Z","timestamp":1793051800018,"version":"4.5.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,12]]},"DOI":"10.7759\/cureus.37509","type":"journal-article","created":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T00:49:42Z","timestamp":1681346982000},"source":"Crossref","is-referenced-by-count":39,"title":["Colon Cancer Screening Methods: 2023 Update"],"prefix":"10.7759","author":[{"given":"Maleesha","family":"Jayasinghe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omesh","family":"Prathiraja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilushini","family":"Caldera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Jena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Anwar","family":"Coffie-Pierre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minollie Suzanne","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozair S","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray F","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018, 68:394-424. 10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-021-00916-7","article-title":"Nanomedicines in the treatment of colon cancer: a focus on metallodrugs","volume":"12","author":"Farinha P","year":"2022","unstructured":"Farinha P, Pinho JO, Matias M, Gaspar MM. Nanomedicines in the treatment of colon cancer: a focus on metallodrugs. Drug Deliv Transl Res. 2022, 12:49-66. 10.1007\/s13346-021-00916-7","journal-title":"Drug Deliv Transl Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23020724","article-title":"Gold (III) derivatives in colon cancer treatment","volume":"23","author":"Gurba A","year":"2022","unstructured":"Gurba A, Taciak P, Sacharczuk M, M\u0142ynarczuk-Bia\u0142y I, Bujalska-Zadro\u017cny M, Fichna J. Gold (III) derivatives in colon cancer treatment. Int J Mol Sci. 2022, 23:724. 10.3390\/ijms23020724","journal-title":"Int J Mol Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/genes13050807","article-title":"Cancer-testis gene biomarkers discovered in colon cancer patients","volume":"13","author":"Almutairi MH","year":"2022","unstructured":"Almutairi MH, Alrubie TM, Alamri AM, et al.. Cancer-testis gene biomarkers discovered in colon cancer patients. Genes (Basel). 2022, 13:807. 10.3390\/genes13050807","journal-title":"Genes (Basel)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1100370","article-title":"Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths","volume":"366","author":"Zauber AG","year":"2012","unstructured":"Zauber AG, Winawer SJ, O'Brien MJ, et al.. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012, 366:687-96. 10.1056\/NEJMoa1100370","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199312303292701","article-title":"Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup","volume":"329","author":"Winawer SJ","year":"1993","unstructured":"Winawer SJ, Zauber AG, Ho MN, et al.. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med. 1993, 329:1977-81. 10.1056\/NEJM199312303292701","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000001122","article-title":"ACG Clinical Guidelines: colorectal cancer screening 2021","volume":"116","author":"Shaukat A","year":"2021","unstructured":"Shaukat A, Kahi CJ, Burke CA, Rabeneck L, Sauer BG, Rex DK. ACG Clinical Guidelines: colorectal cancer screening 2021. Am J Gastroenterol. 2021, 116:458-79. 10.14309\/ajg.0000000000001122","journal-title":"Am J Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21457","article-title":"Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society","volume":"68","author":"Wolf AM","year":"2018","unstructured":"Wolf AM, Fontham ET, Church TR, et al.. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin. 2018, 68:250-81. 10.3322\/caac.21457","journal-title":"CA Cancer J Clin"},{"key":"ref9","article-title":"Colonoscopy Atlas of colon polyps and neoplasms","volume":"57","author":"Tang SJ","year":"2016","unstructured":"Tang SJ, Sones JQ. Colonoscopy Atlas of colon polyps and neoplasms. J Miss State Med Assoc. 2016, 57:68-71.","journal-title":"J Miss State Med Assoc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/njcp.njcp_150_22","article-title":"Colonoscopy in Zaria: indications and findings","volume":"25","author":"Manko M","year":"2022","unstructured":"Manko M, Bello AK, Mohammed MF, et al.. Colonoscopy in Zaria: indications and findings. Niger J Clin Pract. 2022, 25:1580-3. 10.4103\/njcp.njcp_150_22","journal-title":"Niger J Clin Pract"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2007.12.011","article-title":"Implementation of colonoscopy for mass screening for colon cancer and colonic polyps: efficiency with high quality of care","volume":"37","author":"Mihalko SL","year":"2008","unstructured":"Mihalko SL. Implementation of colonoscopy for mass screening for colon cancer and colonic polyps: efficiency with high quality of care. Gastroenterol Clin North Am. 2008, 37:117-28, vii. 10.1016\/j.gtc.2007.12.011","journal-title":"Gastroenterol Clin North Am"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-019-0756-8","article-title":"Colon cancer in young adults: trends and their implications","volume":"21","author":"Weinberg BA","year":"2019","unstructured":"Weinberg BA, Marshall JL. Colon cancer in young adults: trends and their implications. Curr Oncol Rep. 2019, 21:3. 10.1007\/s11912-019-0756-8","journal-title":"Curr Oncol Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/den.13972","article-title":"Colonoscopy screening and surveillance guidelines","volume":"33","author":"Saito Y","year":"2021","unstructured":"Saito Y, Oka S, Kawamura T, et al.. Colonoscopy screening and surveillance guidelines. Dig Endosc. 2021, 33:486-519. 10.1111\/den.13972","journal-title":"Dig Endosc"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.06.043","article-title":"Strategies for colorectal cancer screening","volume":"158","author":"Ladabaum U","year":"2020","unstructured":"Ladabaum U, Dominitz JA, Kahi C, Schoen RE. Strategies for colorectal cancer screening. Gastroenterology. 2020, 158:418-32. 10.1053\/j.gastro.2019.06.043","journal-title":"Gastroenterology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i43.16178","article-title":"Management of malignant colon polyps: current status and controversies","volume":"20","author":"Aarons CB","year":"2014","unstructured":"Aarons CB, Shanmugan S, Bleier JI. Management of malignant colon polyps: current status and controversies. World J Gastroenterol. 2014, 20:16178-83. 10.3748\/wjg.v20.i43.16178","journal-title":"World J Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.tgie.2013.02.005","article-title":"Quality indicators for colorectal cancer screening for colonoscopy","volume":"15","author":"Schoenfeld PS","year":"2013","unstructured":"Schoenfeld PS, Cohen J. Quality indicators for colorectal cancer screening for colonoscopy. Tech Gastrointest Endosc. 2013, 15:59-68. 10.1016\/j.tgie.2013.02.005","journal-title":"Tech Gastrointest Endosc"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.1016\/S1052-5157(18)30293-9","article-title":"Colon cancer screening. Sigmoidoscopy or colonoscopy","volume":"7","author":"Khullar SK","year":"1997","unstructured":"Khullar SK, DiSario JA. Colon cancer screening. Sigmoidoscopy or colonoscopy. Gastrointest Endosc Clin N Am. 1997, 7:365-86.","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2208375","article-title":"Effect of colonoscopy screening on risks of colorectal cancer and related death","volume":"387","author":"Bretthauer M","year":"2022","unstructured":"Bretthauer M, L\u00f8berg M, Wieszczy P, et al.. Effect of colonoscopy screening on risks of colorectal cancer and related death. N Engl J Med. 2022, 387:1547-56. 10.1056\/NEJMoa2208375","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.34375","article-title":"Polyp detection rate and cumulative incidence of post-colonoscopy colorectal cancer in Germany","volume":"152","author":"Schwarz S","year":"2023","unstructured":"Schwarz S, Hornschuch M, Pox C, Haug U. Polyp detection rate and cumulative incidence of post-colonoscopy colorectal cancer in Germany. Int J Cancer. 2023, 152:1547-55. 10.1002\/ijc.34375","journal-title":"Int J Cancer"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-022-12973-4","article-title":"Colonoscopy-assisted laparoscopic wedge resection for the treatment of suspected T1 colon cancer","volume":"30","author":"Hanevelt J","year":"2023","unstructured":"Hanevelt J, Moons LM, Hentzen JE, Wemeijer TM, Huisman JF, de Vos Tot Nederveen Cappel WH, van Westreenen HL. Colonoscopy-assisted laparoscopic wedge resection for the treatment of suspected T1 colon cancer. Ann Surg Oncol. 2023, 30:2058-65. 10.1245\/s10434-022-12973-4","journal-title":"Ann Surg Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2022.07.006","article-title":"Artificial intelligence-assisted colonoscopy for colorectal cancer screening: a multicenter randomized controlled trial","volume":"21","author":"Xu H","year":"2023","unstructured":"Xu H, Tang RS, Lam TY, et al.. Artificial intelligence-assisted colonoscopy for colorectal cancer screening: a multicenter randomized controlled trial. Clin Gastroenterol Hepatol. 2023, 21:337-46.e3. 10.1016\/j.cgh.2022.07.006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.puhe.2019.09.021","article-title":"Enhancing bowel screening: preventing colorectal cancer by flexible sigmoidoscopy in New Zealand","volume":"179","author":"Cox B","year":"2020","unstructured":"Cox B, Sneyd MJ, Hingston G, McBride D, Bagshaw PF. Enhancing bowel screening: preventing colorectal cancer by flexible sigmoidoscopy in New Zealand. Public Health. 2020, 179:27-37. 10.1016\/j.puhe.2019.09.021","journal-title":"Public Health"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009259.pub2","article-title":"Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals","volume":"2013","author":"Holme \u00d8","year":"2013","unstructured":"Holme \u00d8, Bretthauer M, Fretheim A, Odgaard-Jensen J, Hoff G. Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals. Cochrane Database Syst Rev. 2013, 2013:CD009259. 10.1002\/14651858.CD009259.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref24","article-title":"Colorectal cancer screening and prevention","volume":"97","author":"Wilkins T","year":"2018","unstructured":"Wilkins T, McMechan D, Talukder A. Colorectal cancer screening and prevention. Am Fam Physician. 2018, 97:658-65.","journal-title":"Am Fam Physician"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.5809","article-title":"Association of colonoscopy adenoma findings with long-term colorectal cancer incidence","volume":"319","author":"Click B","year":"2018","unstructured":"Click B, Pinsky PF, Hickey T, Doroudi M, Schoen RE. Association of colonoscopy adenoma findings with long-term colorectal cancer incidence. JAMA. 2018, 319:2021-31. 10.1001\/jama.2018.5809","journal-title":"JAMA"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-019-03300-7","article-title":"Screening flexible sigmoidoscopy versus colonoscopy for reduction of colorectal cancer mortality","volume":"34","author":"Ko CW","year":"2019","unstructured":"Ko CW, Doria-Rose VP, Barrett MJ, Kamineni A, Enewold L, Weiss NS. Screening flexible sigmoidoscopy versus colonoscopy for reduction of colorectal cancer mortality. Int J Colorectal Dis. 2019, 34:1273-81. 10.1007\/s00384-019-03300-7","journal-title":"Int J Colorectal Dis"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.5746","article-title":"Colorectal cancer screening: an updated modeling study for the US Preventive Services Task Force","volume":"325","author":"Knudsen AB","year":"2021","unstructured":"Knudsen AB, Rutter CM, Peterse EF, et al.. Colorectal cancer screening: an updated modeling study for the US Preventive Services Task Force. JAMA. 2021, 325:1998-2011. 10.1001\/jama.2021.5746","journal-title":"JAMA"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.4417","article-title":"Screening for colorectal cancer: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"325","author":"Lin JS","year":"2021","unstructured":"Lin JS, Perdue LA, Henrikson NB, Bean SI, Blasi PR. Screening for colorectal cancer: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2021, 325:1978-98. 10.1001\/jama.2021.4417","journal-title":"JAMA"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-022-00962-4","article-title":"Optimal strategies for colorectal cancer screening","volume":"23","author":"Jain S","year":"2022","unstructured":"Jain S, Maque J, Galoosian A, Osuna-Garcia A, May FP. Optimal strategies for colorectal cancer screening. Curr Treat Options Oncol. 2022, 23:474-93. 10.1007\/s11864-022-00962-4","journal-title":"Curr Treat Options Oncol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_16_22","article-title":"The yield of fecal occult blood testing as a screening tool for colon cancer in a primary care setting","volume":"11","author":"Almoneef NM","year":"2022","unstructured":"Almoneef NM, Alkhenizan AH, Mahmoud AS, Alsoghayer SA, Aldheshe AA. The yield of fecal occult blood testing as a screening tool for colon cancer in a primary care setting. J Family Med Prim Care. 2022, 11:4435-9. 10.4103\/jfmpc.jfmpc_16_22","journal-title":"J Family Med Prim Care"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-032773","article-title":"Colorectal cancer screening with faecal testing, sigmoidoscopy or colonoscopy: a systematic review and network meta-analysis","volume":"9","author":"Jodal HC","year":"2019","unstructured":"Jodal HC, Helsingen LM, Anderson JC, Lytvyn L, Vandvik PO, Emilsson L. Colorectal cancer screening with faecal testing, sigmoidoscopy or colonoscopy: a systematic review and network meta-analysis. BMJ Open. 2019, 9:e032773. 10.1136\/bmjopen-2019-032773","journal-title":"BMJ Open"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-83007-4","article-title":"Effects of antithrombotic drugs on the results of fecal immunochemical test in colorectal neoplasms screening","volume":"11","author":"Ibuka T","year":"2021","unstructured":"Ibuka T, Adachi S, Horibe Y, et al.. Effects of antithrombotic drugs on the results of fecal immunochemical test in colorectal neoplasms screening. Sci Rep. 2021, 11:4348. 10.1038\/s41598-021-83007-4","journal-title":"Sci Rep"},{"key":"ref33","unstructured":"Sundhedsstyrelsen. (2012). Accessed. August 30, 2012: https:\/\/www.sst.dk\/da\/udgivelser\/2012\/."},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1055\/a-1743-2651","article-title":"Using fecal immunochemical test values below conventional cut-off to individualize colorectal cancer screening","volume":"10","author":"Plantener E","year":"2022","unstructured":"Plantener E, Deding U, Madsen JB, Kroijer R, Madsen JS, Baatrup G. Using fecal immunochemical test values below conventional cut-off to individualize colorectal cancer screening. Endosc Int Open. 2022, 10:E413-9. 10.1055\/a-1743-2651","journal-title":"Endosc Int Open"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-013-1867-7","article-title":"FIT false-positives in colorectal cancer screening experience psychological distress up to 6 weeks after colonoscopy","volume":"21","author":"Denters MJ","year":"2013","unstructured":"Denters MJ, Deutekom M, Essink-Bot ML, Bossuyt PM, Fockens P, Dekker E. FIT false-positives in colorectal cancer screening experience psychological distress up to 6 weeks after colonoscopy. Support Care Cancer. 2013, 21:2809-15. 10.1007\/s00520-013-1867-7","journal-title":"Support Care Cancer"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-021-07160-6","article-title":"Predictive modeling of colonoscopic findings in a fecal immunochemical test-based colorectal cancer screening program","volume":"67","author":"Law J","year":"2022","unstructured":"Law J, Rajan A, Trieu H, Azizian J, Berry R, Beaven SW, Tabibian JH. Predictive modeling of colonoscopic findings in a fecal immunochemical test-based colorectal cancer screening program. Dig Dis Sci. 2022, 67:2842-8. 10.1007\/s10620-021-07160-6","journal-title":"Dig Dis Sci"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000000588","article-title":"Risk factors for false fecal immunochemical test results in colorectal cancer screening","volume":"51","author":"Kim NH","year":"2017","unstructured":"Kim NH, Park JH, Park DI, Sohn CI, Choi K, Jung YS. Risk factors for false fecal immunochemical test results in colorectal cancer screening. J Clin Gastroenterol. 2017, 51:151-9. 10.1097\/MCG.0000000000000588","journal-title":"J Clin Gastroenterol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1111\/1751-2980.12711","article-title":"Quantitative immunochemical fecal occult blood test for neoplasia in colon cancer screening","volume":"20","author":"Yuan SY","year":"2019","unstructured":"Yuan SY, Wu W, Fu J, et al.. Quantitative immunochemical fecal occult blood test for neoplasia in colon cancer screening. J Dig Dis. 2019, 20:78-82. 10.1111\/1751-2980.12711","journal-title":"J Dig Dis"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.01.025","article-title":"Sensitivity of fecal immunochemical test for colorectal cancer detection differs according to stage and location","volume":"18","author":"Niedermaier T","year":"2020","unstructured":"Niedermaier T, Tikk K, Gies A, Bieck S, Brenner H. Sensitivity of fecal immunochemical test for colorectal cancer detection differs according to stage and location. Clin Gastroenterol Hepatol. 2020, 18:2920-8.e6. 10.1016\/j.cgh.2020.01.025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-322545","article-title":"Long-term effectiveness of faecal immunochemical test screening for proximal and distal colorectal cancers","volume":"70","author":"Chiu HM","year":"2021","unstructured":"Chiu HM, Jen GH, Wang YW, et al.. Long-term effectiveness of faecal immunochemical test screening for proximal and distal colorectal cancers. Gut. 2021, 70:2321-9. 10.1136\/gutjnl-2020-322545","journal-title":"Gut"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v8.i5.450","article-title":"Multitarget stool DNA for colorectal cancer screening: a review and commentary on the United States Preventive Services Draft Guidelines","volume":"8","author":"Berger BM","year":"2016","unstructured":"Berger BM, Levin B, Hilsden RJ. Multitarget stool DNA for colorectal cancer screening: a review and commentary on the United States Preventive Services Draft Guidelines. World J Gastrointest Oncol. 2016, 8:450-8. 10.4251\/wjgo.v8.i5.450","journal-title":"World J Gastrointest Oncol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-103018-123125","article-title":"Fecal DNA testing for colorectal cancer screening","volume":"71","author":"Carethers JM","year":"2020","unstructured":"Carethers JM. Fecal DNA testing for colorectal cancer screening. Annu Rev Med. 2020, 71:59-69. 10.1146\/annurev-med-103018-123125","journal-title":"Annu Rev Med"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1177\/00031348211031844","article-title":"Retrospective review of multitarget stool DNA as a screening test for colorectal cancer","author":"Kleinschmidt TK","year":"2021","unstructured":"Kleinschmidt TK, Clements A, Parker MA, Scarcliff SD. Retrospective review of multitarget stool DNA as a screening test for colorectal cancer. Am Surg. 2021, 31348211031844. 10.1177\/00031348211031844","journal-title":"Am Surg"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2019.12.027","article-title":"Multitarget stool DNA testing for the prevention of colon cancer: outcomes in a large integrated healthcare system","volume":"92","author":"Vakil N","year":"2020","unstructured":"Vakil N, Ciezki K, Huq N, Singh M. Multitarget stool DNA testing for the prevention of colon cancer: outcomes in a large integrated healthcare system. Gastrointest Endosc. 2020, 92:334-41. 10.1016\/j.gie.2019.12.027","journal-title":"Gastrointest Endosc"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0220234","article-title":"Cost-effectiveness of a multitarget stool DNA test for colorectal cancer screening of medicare beneficiaries","volume":"14","author":"Naber SK","year":"2019","unstructured":"Naber SK, Knudsen AB, Zauber AG, et al.. Cost-effectiveness of a multitarget stool DNA test for colorectal cancer screening of medicare beneficiaries. PLoS One. 2019, 14:e0220234. 10.1371\/journal.pone.0220234","journal-title":"PLoS One"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.06.003","article-title":"Comparative effectiveness and cost effectiveness of a multitarget stool DNA test to screen for colorectal neoplasia","volume":"151","author":"Ladabaum U","year":"2016","unstructured":"Ladabaum U, Mannalithara A. Comparative effectiveness and cost effectiveness of a multitarget stool DNA test to screen for colorectal neoplasia. Gastroenterology. 2016, 151:427-39.e6. 10.1053\/j.gastro.2016.06.003","journal-title":"Gastroenterology"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1038\/35013140","article-title":"Wireless capsule endoscopy","volume":"405","author":"Iddan G","year":"2000","unstructured":"Iddan G, Meron G, Glukhovsky A, Swain P. Wireless capsule endoscopy. Nature. 2000, 405:417. 10.1038\/35013140","journal-title":"Nature"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-944832","article-title":"Evaluation of the PillCam Colon capsule in the detection of colonic pathology: results of the first multicenter, prospective, comparative study","volume":"38","author":"Eliakim R","year":"2006","unstructured":"Eliakim R, Fireman Z, Gralnek IM, et al.. Evaluation of the PillCam Colon capsule in the detection of colonic pathology: results of the first multicenter, prospective, comparative study. Endoscopy. 2006, 38:963-70. 10.1055\/s-2006-944832","journal-title":"Endoscopy"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0806347","article-title":"Capsule endoscopy versus colonoscopy for the detection of polyps and cancer","volume":"361","author":"Van Gossum A","year":"2009","unstructured":"Van Gossum A, Munoz-Navas M, Fernandez-Urien I, et al.. Capsule endoscopy versus colonoscopy for the detection of polyps and cancer. N Engl J Med. 2009, 361:264-70. 10.1056\/NEJMoa0806347","journal-title":"N Engl J Med"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1215360","article-title":"Prospective multicenter performance evaluation of the second-generation colon capsule compared with colonoscopy","volume":"41","author":"Eliakim R","year":"2009","unstructured":"Eliakim R, Yassin K, Niv Y, et al.. Prospective multicenter performance evaluation of the second-generation colon capsule compared with colonoscopy. Endoscopy. 2009, 41:1026-31. 10.1055\/s-0029-1215360","journal-title":"Endoscopy"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.10.016","article-title":"Effects of colon capsule endoscopy on medical decision making in patients with incomplete colonoscopies","volume":"11","author":"Alarc\u00f3n-Fern\u00e1ndez O","year":"2013","unstructured":"Alarc\u00f3n-Fern\u00e1ndez O, Ramos L, Adri\u00e1n-de-Ganzo Z, Gimeno-Garc\u00eda AZ, Nicol\u00e1s-P\u00e9rez D, Jim\u00e9nez A, Quintero E. Effects of colon capsule endoscopy on medical decision making in patients with incomplete colonoscopies. Clin Gastroenterol Hepatol. 2013, 11:534-40.e1. 10.1016\/j.cgh.2012.10.016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1055\/a-1308-1297","article-title":"Colon capsule endoscopy in colorectal cancer screening: a systematic review","volume":"53","author":"Vuik FE","year":"2021","unstructured":"Vuik FE, Nieuwenburg SA, Moen S, et al.. Colon capsule endoscopy in colorectal cancer screening: a systematic review. Endoscopy. 2021, 53:815-24. 10.1055\/a-1308-1297","journal-title":"Endoscopy"},{"key":"ref53","article-title":"Colonoscopy","author":"Stauffer CM","year":"2022","unstructured":"Stauffer CM, Pfeifer C. Colonoscopy. StatPearls Publishing, Treasure Island, FL; 2022."},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.2344\/anpr-65-04-15w","article-title":"Practice Guidelines for Intravenous Conscious Sedation in Dentistry (Second Edition, 2017)","volume":"65","author":"Working Group on Guidelines Development for Intravenous Sedation in Dentistry","year":"2018","unstructured":"Working Group on Guidelines Development for Intravenous Sedation in Dentistry, the Japanese Dental Society of Anesthesiology. Practice Guidelines for Intravenous Conscious Sedation in Dentistry (Second Edition, 2017). Anesth Prog. 2018, 65:e1-e18. 10.2344\/anpr-65-04-15w","journal-title":"Anesth Prog"},{"key":"ref55","article-title":"Approach to incomplete colonoscopy: new techniques and technologies","volume":"13","author":"Franco DL","year":"2017","unstructured":"Franco DL, Leighton JA, Gurudu SR. Approach to incomplete colonoscopy: new techniques and technologies. Gastroenterol Hepatol (N Y). 2017, 13:476-83.","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1111\/den.13769","article-title":"Current status of colon capsule endoscopy","volume":"33","author":"Hosoe N","year":"2021","unstructured":"Hosoe N, Limpias Kamiya KJ, Hayashi Y, Sujino T, Ogata H, Kanai T. Current status of colon capsule endoscopy. Dig Endosc. 2021, 33:529-37. 10.1111\/den.13769","journal-title":"Dig Endosc"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2011.03.1125","article-title":"Second-generation colon capsule endoscopy compared with colonoscopy","volume":"74","author":"Spada C","year":"2011","unstructured":"Spada C, Hassan C, Munoz-Navas M, et al.. Second-generation colon capsule endoscopy compared with colonoscopy. Gastrointest Endosc. 2011, 74:581-9.e1. 10.1016\/j.gie.2011.03.1125","journal-title":"Gastrointest Endosc"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2019.1584404","article-title":"Addressing priority challenges in the detection and assessment of colorectal polyps from capsule endoscopy and colonoscopy in colorectal cancer screening using machine learning","volume":"58","author":"Blanes-Vidal V","year":"2019","unstructured":"Blanes-Vidal V, Baatrup G, Nadimi ES. Addressing priority challenges in the detection and assessment of colorectal polyps from capsule endoscopy and colonoscopy in colorectal cancer screening using machine learning. Acta Oncol. 2019, 58:S29-36. 10.1080\/0284186X.2019.1584404","journal-title":"Acta Oncol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1186\/s12880-020-00446-7","article-title":"Computed tomography colonography versus colonoscopy for detection of colorectal cancer: a diagnostic performance study","volume":"20","author":"Sha J","year":"2020","unstructured":"Sha J, Chen J, Lv X, Liu S, Chen R, Zhang Z. Computed tomography colonography versus colonoscopy for detection of colorectal cancer: a diagnostic performance study. BMC Med Imaging. 2020, 20:51. 10.1186\/s12880-020-00446-7","journal-title":"BMC Med Imaging"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.3310\/hta19540","article-title":"Computed tomographic colonography compared with colonoscopy or barium enema for diagnosis of colorectal cancer in older symptomatic patients: two multicentre randomised trials with economic evaluation (the SIGGAR trials)","volume":"19","author":"Halligan S","year":"2015","unstructured":"Halligan S, Dadswell E, Wooldrage K, et al.. Computed tomographic colonography compared with colonoscopy or barium enema for diagnosis of colorectal cancer in older symptomatic patients: two multicentre randomised trials with economic evaluation (the SIGGAR trials). Health Technol Assess. 2015, 19:1-134. 10.3310\/hta19540","journal-title":"Health Technol Assess"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.05.021","article-title":"Mass screening with CT colonography: should the radiation exposure be of concern?","volume":"129","author":"Brenner DJ","year":"2005","unstructured":"Brenner DJ, Georgsson MA. Mass screening with CT colonography: should the radiation exposure be of concern?. Gastroenterology. 2005, 129:328-37. 10.1053\/j.gastro.2005.05.021","journal-title":"Gastroenterology"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.12.041","article-title":"Magnetic resonance colonography for the detection of colorectal neoplasia in asymptomatic adults","volume":"144","author":"Graser A","year":"2013","unstructured":"Graser A, Melzer A, Lindner E, et al.. Magnetic resonance colonography for the detection of colorectal neoplasia in asymptomatic adults. Gastroenterology. 2013, 144:743-50.e2. 10.1053\/j.gastro.2012.12.041","journal-title":"Gastroenterology"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1046\/j.1572-0241.2003.04008.x","article-title":"Magnetic resonance colonography in the detection of colonic neoplasm in high-risk and average-risk individuals","volume":"99","author":"Leung WK","year":"2004","unstructured":"Leung WK, Lam WW, Wu JC, et al.. Magnetic resonance colonography in the detection of colonic neoplasm in high-risk and average-risk individuals. Am J Gastroenterol. 2004, 99:102-8. 10.1046\/j.1572-0241.2003.04008.x","journal-title":"Am J Gastroenterol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907667","article-title":"Quality indicators for colonoscopy and the risk of interval cancer","volume":"362","author":"Kaminski MF","year":"2010","unstructured":"Kaminski MF, Regula J, Kraszewska E, et al.. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med. 2010, 362:1795-803. 10.1056\/NEJMoa0907667","journal-title":"N Engl J Med"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.216.2.r00au11383","article-title":"Colonic masses: detection with MR colonography","volume":"216","author":"Luboldt W","year":"2000","unstructured":"Luboldt W, Bauerfeind P, Wildermuth S, Marincek B, Fried M, Debatin JF. Colonic masses: detection with MR colonography. Radiology. 2000, 216:383-8. 10.1148\/radiology.216.2.r00au11383","journal-title":"Radiology"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.12.1738","article-title":"Dark lumen magnetic resonance colonography: comparison with conventional colonoscopy for the detection of colorectal pathology","volume":"52","author":"Ajaj W","year":"2003","unstructured":"Ajaj W, Pelster G, Treichel U, Vogt FM, Debatin JF, Ruehm SG, Lauenstein TC. Dark lumen magnetic resonance colonography: comparison with conventional colonoscopy for the detection of colorectal pathology. Gut. 2003, 52:1738-43. 10.1136\/gut.52.12.1738","journal-title":"Gut"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2381041756","article-title":"Colorectal polyps: detection with dark-lumen MR colonography versus conventional colonoscopy","volume":"238","author":"Hartmann D","year":"2006","unstructured":"Hartmann D, Bassler B, Schilling D, et al.. Colorectal polyps: detection with dark-lumen MR colonography versus conventional colonoscopy. Radiology. 2006, 238:143-9. 10.1148\/radiol.2381041756","journal-title":"Radiology"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206774","article-title":"Cancer epigenetics","volume":"22","author":"Momparler RL","year":"2003","unstructured":"Momparler RL. Cancer epigenetics. Oncogene. 2003, 22:6479-83. 10.1038\/sj.onc.1206774","journal-title":"Oncogene"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(03)01115-x","article-title":"Relevance of DNA methylation in the management of cancer","volume":"4","author":"Esteller M","year":"2003","unstructured":"Esteller M. Relevance of DNA methylation in the management of cancer. Lancet Oncol. 2003, 4:351-8. 10.1016\/s1470-2045(03)01115-x","journal-title":"Lancet Oncol"},{"key":"ref70","article-title":"Detection of aberrant p16 methylation in the serum of colorectal cancer patients","volume":"8","author":"Zou HZ","year":"2002","unstructured":"Zou HZ, Yu BM, Wang ZW, et al.. Detection of aberrant p16 methylation in the serum of colorectal cancer patients. Clin Cancer Res. 2002, 8:188-91.","journal-title":"Clin Cancer Res"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.07.011","article-title":"Epigenetic alterations in colorectal cancer: emerging biomarkers","volume":"149","author":"Okugawa Y","year":"2015","unstructured":"Okugawa Y, Grady WM, Goel A. Epigenetic alterations in colorectal cancer: emerging biomarkers. Gastroenterology. 2015, 149:1204-25.e12. 10.1053\/j.gastro.2015.07.011","journal-title":"Gastroenterology"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16002-9","article-title":"Methylation changes in faecal DNA: a marker for colorectal cancer screening?","volume":"363","author":"M\u00fcller HM","year":"2004","unstructured":"M\u00fcller HM, Oberwalder M, Fiegl H, et al.. Methylation changes in faecal DNA: a marker for colorectal cancer screening?. Lancet. 2004, 363:1283-5. 10.1016\/S0140-6736(04)16002-9","journal-title":"Lancet"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i38.14040","article-title":"Accuracy of early detection of colorectal tumours by stool methylation markers: a meta-analysis","volume":"20","author":"Zhang H","year":"2014","unstructured":"Zhang H, Qi J, Wu YQ, Zhang P, Jiang J, Wang QX, Zhu YQ. Accuracy of early detection of colorectal tumours by stool methylation markers: a meta-analysis. World J Gastroenterol. 2014, 20:14040-50. 10.3748\/wjg.v20.i38.14040","journal-title":"World J Gastroenterol"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-007-9755-y","article-title":"Hypermethylation of SFRP2 as a potential marker for stool-based detection of colorectal cancer and precancerous lesions","volume":"52","author":"Huang Z","year":"2007","unstructured":"Huang Z, Li L, Wang J. Hypermethylation of SFRP2 as a potential marker for stool-based detection of colorectal cancer and precancerous lesions. Dig Dis Sci. 2007, 52:2287-91. 10.1007\/s10620-007-9755-y","journal-title":"Dig Dis Sci"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dji204","article-title":"Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene","volume":"97","author":"Chen WD","year":"2005","unstructured":"Chen WD, Han ZJ, Skoletsky J, et al.. Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. J Natl Cancer Inst. 2005, 97:1124-32. 10.1093\/jnci\/dji204","journal-title":"J Natl Cancer Inst"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-0142","article-title":"Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer","volume":"69","author":"Gl\u00f6ckner SC","year":"2009","unstructured":"Gl\u00f6ckner SC, Dhir M, Yi JM, et al.. Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. Cancer Res. 2009, 69:4691-9. 10.1158\/0008-5472.CAN-08-0142","journal-title":"Cancer Res"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-0055","article-title":"GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer","volume":"15","author":"Hellebrekers DM","year":"2009","unstructured":"Hellebrekers DM, Lentjes MH, van den Bosch SM, et al.. GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer. Clin Cancer Res. 2009, 15:3990-7. 10.1158\/1078-0432.CCR-09-0055","journal-title":"Clin Cancer Res"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-022-02264-3","article-title":"A novel method for early detection of colorectal cancer based on detection of methylation of two fragments of syndecan-2 (SDC2) in stool DNA","volume":"22","author":"Ma L","year":"2022","unstructured":"Ma L, Qin G, Gai F, et al.. A novel method for early detection of colorectal cancer based on detection of methylation of two fragments of syndecan-2 (SDC2) in stool DNA. BMC Gastroenterol. 2022, 22:191. 10.1186\/s12876-022-02264-3","journal-title":"BMC Gastroenterol"},{"key":"ref79","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.1203.11.3","article-title":"Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps","volume":"11","author":"Petko Z","year":"2005","unstructured":"Petko Z, Ghiassi M, Shuber A, et al.. Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps. Clin Cancer Res. 2005, 11:1203-9.","journal-title":"Clin Cancer Res"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djp131","article-title":"N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer","volume":"101","author":"Melotte V","year":"2009","unstructured":"Melotte V, Lentjes MH, van den Bosch SM, et al.. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer. J Natl Cancer Inst. 2009, 101:916-27. 10.1093\/jnci\/djp131","journal-title":"J Natl Cancer Inst"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1311194","article-title":"Multitarget stool DNA testing for colorectal-cancer screening","volume":"370","author":"Imperiale TF","year":"2014","unstructured":"Imperiale TF, Ransohoff DF, Itzkowitz SH, et al.. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014, 370:1287-97. 10.1056\/NEJMoa1311194","journal-title":"N Engl J Med"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-0111","article-title":"Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer","volume":"15","author":"Lee BB","year":"2009","unstructured":"Lee BB, Lee EJ, Jung EH, et al.. Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer. Clin Cancer Res. 2009, 15:6185-91. 10.1158\/1078-0432.CCR-09-0111","journal-title":"Clin Cancer Res"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2007.095992","article-title":"DNA methylation biomarkers for blood-based colorectal cancer screening","volume":"54","author":"Lofton-Day C","year":"2008","unstructured":"Lofton-Day C, Model F, Devos T, et al.. DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem. 2008, 54:414-23. 10.1373\/clinchem.2007.095992","journal-title":"Clin Chem"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12855","article-title":"Performance of a second-generation methylated SEPT9 test in detecting colorectal neoplasm","volume":"30","author":"Jin P","year":"2015","unstructured":"Jin P, Kang Q, Wang X, et al.. Performance of a second-generation methylated SEPT9 test in detecting colorectal neoplasm. J Gastroenterol Hepatol. 2015, 30:830-3. 10.1111\/jgh.12855","journal-title":"J Gastroenterol Hepatol"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1111\/codi.12318","article-title":"The prognostic significance of APC gene mutation and miR-21 expression in advanced-stage colorectal cancer","volume":"15","author":"Chen TH","year":"2013","unstructured":"Chen TH, Chang SW, Huang CC, et al.. The prognostic significance of APC gene mutation and miR-21 expression in advanced-stage colorectal cancer. Colorectal Dis. 2013, 15:1367-74. 10.1111\/codi.12318","journal-title":"Colorectal Dis"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2005.04.039","article-title":"A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis","volume":"41","author":"Popat S","year":"2005","unstructured":"Popat S, Houlston RS. A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis. Eur J Cancer. 2005, 41:2060-70. 10.1016\/j.ejca.2005.04.039","journal-title":"Eur J Cancer"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1202178","article-title":"MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas","volume":"17","author":"Esteller M","year":"1998","unstructured":"Esteller M, Levine R, Baylin SB, Ellenson LH, Herman JG. MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas. Oncogene. 1998, 17:2413-7. 10.1038\/sj.onc.1202178","journal-title":"Oncogene"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2015.1022071","article-title":"VEGF and dual-EGFR inhibition in colorectal cancer","volume":"14","author":"Falchook GS","year":"2015","unstructured":"Falchook GS, Kurzrock R. VEGF and dual-EGFR inhibition in colorectal cancer. Cell Cycle. 2015, 14:1129-30. 10.1080\/15384101.2015.1022071","journal-title":"Cell Cycle"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(94)90161-9","article-title":"Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis","volume":"107","author":"Brentnall TA","year":"1994","unstructured":"Brentnall TA, Crispin DA, Rabinovitch PS, et al.. Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology. 1994, 107:369-78. 10.1016\/0016-5085(94)90161-9","journal-title":"Gastroenterology"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2013.1458","article-title":"Insulin-like growth factor-II mRNA-binding protein 3 predicts a poor prognosis for colorectal adenocarcinoma","volume":"6","author":"Lin L","year":"2013","unstructured":"Lin L, Zhang J, Wang Y, Ju W, Ma Y, Li L, Chen L. Insulin-like growth factor-II mRNA-binding protein 3 predicts a poor prognosis for colorectal adenocarcinoma. Oncol Lett. 2013, 6:740-4. 10.3892\/ol.2013.1458","journal-title":"Oncol Lett"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2014.11.003","article-title":"A meta-analysis of SMAD4 immunohistochemistry as a prognostic marker in colorectal cancer","volume":"8","author":"Voorneveld PW","year":"2015","unstructured":"Voorneveld PW, Jacobs RJ, Kodach LL, Hardwick JC. A meta-analysis of SMAD4 immunohistochemistry as a prognostic marker in colorectal cancer. Transl Oncol. 2015, 8:18-24. 10.1016\/j.tranon.2014.11.003","journal-title":"Transl Oncol"},{"key":"ref92","article-title":"Germ-line msh6 mutations in colorectal cancer families","volume":"59","author":"Kolodner RD","year":"1999","unstructured":"Kolodner RD, Tytell JD, Schmeits JL, et al.. Germ-line msh6 mutations in colorectal cancer families. Cancer Res. 1999, 59:5068-74.","journal-title":"Cancer Res"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra012242","article-title":"Hereditary colorectal cancer","volume":"348","author":"Lynch HT","year":"2003","unstructured":"Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med. 2003, 348:919-32. 10.1056\/NEJMra012242","journal-title":"N Engl J Med"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0149626","article-title":"Clinical relevance of telomere status and telomerase activity in colorectal cancer","volume":"11","author":"Fern\u00e1ndez-Marcelo T","year":"2016","unstructured":"Fern\u00e1ndez-Marcelo T, S\u00e1nchez-Pernaute A, Pascua I, De Juan C, Head J, Torres-Garc\u00eda AJ, Iniesta P. Clinical relevance of telomere status and telomerase activity in colorectal cancer. PLoS One. 2016, 11:e0149626. 10.1371\/journal.pone.0149626","journal-title":"PLoS One"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2668","article-title":"Plasma insulin-like growth factor-binding protein-2 levels as diagnostic and prognostic biomarker of colorectal cancer","volume":"95","author":"Liou JM","year":"2010","unstructured":"Liou JM, Shun CT, Liang JT, et al.. Plasma insulin-like growth factor-binding protein-2 levels as diagnostic and prognostic biomarker of colorectal cancer. J Clin Endocrinol Metab. 2010, 95:1717-25. 10.1210\/jc.2009-2668","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/145520-colon-cancer-screening-methods-2023-update","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T14:59:10Z","timestamp":1707490750000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/145520-colon-cancer-screening-methods-2023-update"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,12]]},"references-count":95,"URL":"https:\/\/doi.org\/10.7759\/cureus.37509","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,12]]}}}